Quarterly report · Q2
7716.TEDINET S100OVJK
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.5bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥44.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.0bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥8.1bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥7.6bn | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥9.5bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥14.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.4bn | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥9.5bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥7.4bn | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.8bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.1bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.4bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥6.8bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥5.4bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥98.9bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥94.5bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥89.9bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.7bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥11.5bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥89.2bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥82.9bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥81.2bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥36.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥36.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥33.9bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥36.1bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.8bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥12.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.1bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.4bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.1bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥626m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.8bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.3bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥78.52 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.02 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.73 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.93 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.45 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥78.33 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.47 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.8 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 89.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.0% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥8.7bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥774m |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.7bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.7bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥885m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥24.5bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥24.5bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥10.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥2.1bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥19.9bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥19.9bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥8.5bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥660m |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥655m |
| —segment total | revenue | 2021-01-01 → 2021-06-30 | ¥23.0bn |
| —segment total | revenue external | 2021-01-01 → 2021-06-30 | ¥23.0bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥9.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 528
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net inv cf | Prior1YTDDuration | 5018000 | JPY |
| Other net inv cf | CurrentYTDDuration | 3838000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -626001000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -3363793000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -1300074000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -1722570000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -92000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -1077655000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -1300166000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -2800225000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 877422000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 2365212000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 6060092000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -993595000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 30044771000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 34887816000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 36104863000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 33894220000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 2074355000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 2254096000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 78073000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 79072000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 19872108000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 1351441000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 1790702000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 23014252000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 23014252000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 19872108000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 1351441000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 1790702000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 23014252000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Net sales | Prior1YTDDuration | 23014252000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 8452160000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 654795000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 660201000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 9767158000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -2120497000 | JPY |
| Operating income | Prior1YTDDuration | 7646660000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 20530662000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 1681197000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 2250354000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 24462214000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |